US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist

0.955
-0.075-7.29%

Close Jul 24 16:00 ET

131.38MMarket Cap-2728P/E (TTM)

Compass Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-13.57%-13.89M

-19.03%-40.62M

-16.10%-12.35M

45.88%-5.92M

-119.85%-10.11M

-53.98%-12.23M

-73.52%-34.13M

-128.10%-10.64M

-216.52%-10.94M

22.55%-4.6M

Net income from continuing operations

-37.64%-10.79M

-8.33%-42.49M

-15.71%-13.42M

16.79%-9.96M

-32.78%-11.28M

-9.42%-7.84M

52.27%-39.23M

10.68%-11.59M

-100.35%-11.98M

84.78%-8.49M

Operating gains losses

----

-66.67%-70K

--0

----

Depreciation and amortization

-3.74%463K

-0.74%1.89M

-3.31%468K

-4.31%466K

-4.62%475K

10.57%481K

17.24%1.9M

22.22%484K

19.95%487K

21.76%498K

Change In working capital

6.42%-5.19M

-130.25%-2.91M

-454.55%-195K

720.63%2.74M

-94.93%97K

-98.89%-5.55M

-120.22%-1.26M

-99.18%55K

-138.52%-441K

191.92%1.91M

-Change in prepaid assets

-274.40%-936K

220.94%6.76M

123.45%1.46M

532.87%3.64M

38.85%1.91M

80.96%-250K

-1,147.00%-5.59M

-1,422.72%-6.23M

118.63%575K

200.29%1.38M

-Change in payables and accrued expense

21.36%-3.94M

-255.95%-8.47M

-120.49%-1.35M

18.78%-601K

-287.98%-1.52M

-314.93%-5M

-20.40%5.43M

-0.29%6.57M

-165.26%-740K

276.20%807K

-Change in other current liabilities

-9.22%-320K

-9.07%-1.2M

-9.15%-310K

-9.06%-301K

-9.56%-298K

-8.52%-293K

0.81%-1.1M

21.98%-284K

-9.52%-276K

-9.24%-272K

Cash from discontinued investing activities

Operating cash flow

-13.57%-13.89M

-19.03%-40.62M

-16.10%-12.35M

45.88%-5.92M

-119.85%-10.11M

-53.98%-12.23M

-73.52%-34.13M

-128.10%-10.64M

-216.52%-10.94M

22.55%-4.6M

Investing cash flow

Cash flow from continuing investing activities

-196.02%-4.1M

117.83%26.97M

113.54%6.31M

1,344.83%17.05M

99.37%-667K

2,311.92%4.27M

-8,442.37%-151.2M

-5,911.08%-46.65M

421.53%1.18M

-17,089.09%-105.54M

Net PPE purchase and sale

----

16.67%-30K

83.33%-9K

62.96%-10K

----

97.52%-36K

93.04%-54K

92.64%-27K

180.41%238K

Net investment purchase and sale

-196.02%-4.1M

117.86%27M

113.57%6.32M

1,313.34%17.06M

99.38%-656K

--4.27M

---151.16M

---46.59M

--1.21M

---105.78M

Cash from discontinued investing activities

Investing cash flow

-196.02%-4.1M

117.83%26.97M

113.54%6.31M

1,344.83%17.05M

99.37%-667K

2,311.92%4.27M

-8,442.37%-151.2M

-5,911.08%-46.65M

421.53%1.18M

-17,089.09%-105.54M

Financing cash flow

Cash flow from continuing financing activities

42,419.51%17.43M

-96.13%2.94M

-100.21%-158K

320.00%21K

3.03M

41K

-36.13%75.76M

-39.03%75.75M

100.27%5K

Net common stock issuance

--18.11M

-95.90%3.13M

--0

--3.13M

--0

-40.56%76.24M

--0

----

Proceeds from stock option exercised by employees

--0

313.33%62K

--0

320.00%21K

--0

--41K

--15K

--10K

--5K

--0

Net other financing activities

---680K

48.89%-253K

---158K

--0

----

-76.16%-495K

----

Cash from discontinued financing activities

Financing cash flow

42,419.51%17.43M

-96.13%2.94M

-100.21%-158K

320.00%21K

--3.03M

--41K

-36.13%75.76M

-39.03%75.75M

100.27%5K

--0

Net cash flow

Beginning cash position

-30.67%24.23M

-75.82%34.95M

84.61%30.43M

-26.53%19.28M

-80.18%27.03M

-75.82%34.95M

205.27%144.51M

-35.92%16.48M

-16.49%26.24M

242.27%136.38M

Current changes in cash

93.00%-554K

90.22%-10.72M

-133.57%-6.2M

214.26%11.15M

92.96%-7.75M

2.66%-7.92M

-212.75%-109.57M

-84.46%18.47M

-71.21%-9.76M

-1,206.85%-110.14M

End cash Position

-12.41%23.67M

-30.67%24.23M

84.61%30.43M

-26.53%19.28M

-80.18%27.03M

-75.82%34.95M

-35.92%16.48M

-16.49%26.24M

Free cash flow

-13.57%-13.89M

-18.38%-40.65M

-15.60%-12.36M

45.92%-5.93M

-123.14%-10.12M

-50.31%-12.23M

-61.71%-34.34M

-96.53%-10.7M

-186.85%-10.97M

27.23%-4.54M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-13.57%-13.89M	-19.03%-40.62M	-16.10%-12.35M	45.88%-5.92M	-119.85%-10.11M	-53.98%-12.23M	-73.52%-34.13M	-128.10%-10.64M	-216.52%-10.94M	22.55%-4.6M
Net income from continuing operations	-37.64%-10.79M	-8.33%-42.49M	-15.71%-13.42M	16.79%-9.96M	-32.78%-11.28M	-9.42%-7.84M	52.27%-39.23M	10.68%-11.59M	-100.35%-11.98M	84.78%-8.49M
Operating gains losses	----	----	----	----	----	----	-66.67%-70K	--0	--0	----
Depreciation and amortization	-3.74%463K	-0.74%1.89M	-3.31%468K	-4.31%466K	-4.62%475K	10.57%481K	17.24%1.9M	22.22%484K	19.95%487K	21.76%498K
Change In working capital	6.42%-5.19M	-130.25%-2.91M	-454.55%-195K	720.63%2.74M	-94.93%97K	-98.89%-5.55M	-120.22%-1.26M	-99.18%55K	-138.52%-441K	191.92%1.91M
-Change in prepaid assets	-274.40%-936K	220.94%6.76M	123.45%1.46M	532.87%3.64M	38.85%1.91M	80.96%-250K	-1,147.00%-5.59M	-1,422.72%-6.23M	118.63%575K	200.29%1.38M
-Change in payables and accrued expense	21.36%-3.94M	-255.95%-8.47M	-120.49%-1.35M	18.78%-601K	-287.98%-1.52M	-314.93%-5M	-20.40%5.43M	-0.29%6.57M	-165.26%-740K	276.20%807K
-Change in other current liabilities	-9.22%-320K	-9.07%-1.2M	-9.15%-310K	-9.06%-301K	-9.56%-298K	-8.52%-293K	0.81%-1.1M	21.98%-284K	-9.52%-276K	-9.24%-272K
Cash from discontinued investing activities
Operating cash flow	-13.57%-13.89M	-19.03%-40.62M	-16.10%-12.35M	45.88%-5.92M	-119.85%-10.11M	-53.98%-12.23M	-73.52%-34.13M	-128.10%-10.64M	-216.52%-10.94M	22.55%-4.6M
Investing cash flow
Cash flow from continuing investing activities	-196.02%-4.1M	117.83%26.97M	113.54%6.31M	1,344.83%17.05M	99.37%-667K	2,311.92%4.27M	-8,442.37%-151.2M	-5,911.08%-46.65M	421.53%1.18M	-17,089.09%-105.54M
Net PPE purchase and sale	----	16.67%-30K	83.33%-9K	62.96%-10K	----	----	97.52%-36K	93.04%-54K	92.64%-27K	180.41%238K
Net investment purchase and sale	-196.02%-4.1M	117.86%27M	113.57%6.32M	1,313.34%17.06M	99.38%-656K	--4.27M	---151.16M	---46.59M	--1.21M	---105.78M
Cash from discontinued investing activities
Investing cash flow	-196.02%-4.1M	117.83%26.97M	113.54%6.31M	1,344.83%17.05M	99.37%-667K	2,311.92%4.27M	-8,442.37%-151.2M	-5,911.08%-46.65M	421.53%1.18M	-17,089.09%-105.54M
Financing cash flow
Cash flow from continuing financing activities	42,419.51%17.43M	-96.13%2.94M	-100.21%-158K	320.00%21K	3.03M	41K	-36.13%75.76M	-39.03%75.75M	100.27%5K	0
Net common stock issuance	--18.11M	-95.90%3.13M	--0	--0	--3.13M	--0	-40.56%76.24M	-40.56%76.24M	--0	----
Proceeds from stock option exercised by employees	--0	313.33%62K	--0	320.00%21K	--0	--41K	--15K	--10K	--5K	--0
Net other financing activities	---680K	48.89%-253K	---158K	--0	----	----	-76.16%-495K	----	----	----
Cash from discontinued financing activities
Financing cash flow	42,419.51%17.43M	-96.13%2.94M	-100.21%-158K	320.00%21K	--3.03M	--41K	-36.13%75.76M	-39.03%75.75M	100.27%5K	--0
Net cash flow
Beginning cash position	-30.67%24.23M	-75.82%34.95M	84.61%30.43M	-26.53%19.28M	-80.18%27.03M	-75.82%34.95M	205.27%144.51M	-35.92%16.48M	-16.49%26.24M	242.27%136.38M
Current changes in cash	93.00%-554K	90.22%-10.72M	-133.57%-6.2M	214.26%11.15M	92.96%-7.75M	2.66%-7.92M	-212.75%-109.57M	-84.46%18.47M	-71.21%-9.76M	-1,206.85%-110.14M
End cash Position	-12.41%23.67M	-30.67%24.23M	-30.67%24.23M	84.61%30.43M	-26.53%19.28M	-80.18%27.03M	-75.82%34.95M	-75.82%34.95M	-35.92%16.48M	-16.49%26.24M
Free cash flow	-13.57%-13.89M	-18.38%-40.65M	-15.60%-12.36M	45.92%-5.93M	-123.14%-10.12M	-50.31%-12.23M	-61.71%-34.34M	-96.53%-10.7M	-186.85%-10.97M	27.23%-4.54M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall